BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3941271)

  • 1. In vivo or in vitro selection for resistance to natural cytotoxic cell lysis selects for variants with increased tumorigenicity.
    Patek PQ; Lin Y; Collins JL; Cohn M
    J Immunol; 1986 Jan; 136(2):741-5. PubMed ID: 3941271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro selection of a cell line for resistance to lysis by tumor necrosis factor-alpha selects for reduced tumorigenicity.
    Patek PQ; Lin Y
    J Immunol; 1991 May; 146(10):3457-61. PubMed ID: 2026874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity.
    Halachmi E; Witz IP
    Cancer Res; 1989 May; 49(9):2383-9. PubMed ID: 2539901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An analysis of the sensitivity of somatic cell hybrids to natural killer cell- and natural cytotoxic cell-mediated lysis.
    Lin Y; Collins JL; Patek PQ; Cohn M
    J Immunol; 1983 Sep; 131(3):1154-9. PubMed ID: 6604090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Susceptibility of Adenovirus 2-transformed rat cell lines to natural killer (NK) cells: direct correlation between NK resistance and in vivo tumorigenesis.
    Sheil JM; Gallimore PH; Zimmer SG; Sopori ML
    J Immunol; 1984 Mar; 132(3):1578-82. PubMed ID: 6319497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of immune surveillance of sequentially derived cell lines that differ in their tumorigenic potential.
    Lin Y; Patek PQ; Collins JL; Cohn M
    J Natl Cancer Inst; 1985 May; 74(5):1025-30. PubMed ID: 3873568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor growth in vivo selects for resistance to tumor necrosis factor.
    Lattime EC; Stutman O
    J Immunol; 1989 Dec; 143(12):4317-23. PubMed ID: 2592776
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential tumorigenicity of growth factor-dependent versus -independent CCL39 lung fibroblast lines in nude mice.
    Renwick DE; Franchi AJ; Pouysségur JM; Lagarde AE
    J Natl Cancer Inst; 1986 Jul; 77(1):105-14. PubMed ID: 3459908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Natural cytotoxic cells and tumor necrosis factor activate similar lytic mechanisms.
    Patek PQ; Lin Y; Collins JL
    J Immunol; 1987 Mar; 138(5):1641-6. PubMed ID: 3805728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An oligosaccharide biosynthetic defect in concanavalin A-resistant Chinese hamster ovary (CHO) cells that enhances NK reactivity in vitro and in vivo.
    Pohajdak B; Wright JA; Greenberg AJ
    J Immunol; 1984 Nov; 133(5):2423-9. PubMed ID: 6481160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A murine model for B-cell lymphomagenesis in immunocompromised hosts: natural killer cells are an important component of host resistance to premalignant B-cell lines.
    Felsher DW; Rhim SH; Braun J
    Cancer Res; 1990 Nov; 50(21):7050-6. PubMed ID: 2208172
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Immunological and morphological properties of fibroblasts transformed in vitro. II. The change in the susceptibility of FC3H3 cells to lymphocytes--natural killers and macrophages during their selection for malignancy].
    Lavrovskiĭ VA; Iurchenko IuA; Viksler VKh
    Tsitologiia; 1984 Oct; 26(10):1181-5. PubMed ID: 6515718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Some immunological properties of high and low tumorigenic cellular variants of c-H-ras transformed 3T3 cells.
    Gonen B; Ran M; Wreschner D; Cahalon L; Anavi R; Shlomo Y; Witz IP
    Nat Immun Cell Growth Regul; 1988; 7(3):144-54. PubMed ID: 3050475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of the tumorigenic phenotype with in vitro, but not in vivo, passaging of a novel series of human bronchial epithelial cell lines: possible role of an alpha 5/beta 1-integrin-fibronectin interaction.
    Schiller JH; Bittner G
    Cancer Res; 1995 Dec; 55(24):6215-21. PubMed ID: 8521416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunological and morphological properties of in vitro transformed fibroblasts. III. Recognition by macrophages and activated lymphocytes of mouse and rat cells of various degrees of tumorigenicity].
    Lavrovskiĭ VA; Iurchenko IuA; Guvakova MA
    Tsitologiia; 1987 May; 29(5):589-95. PubMed ID: 3617224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that cytotoxic T cells and natural cytotoxic cells use different lytic mechanisms to lyse the same targets.
    Patek PQ; Collins JL; Cohn M
    Eur J Immunol; 1983 May; 13(5):433-6. PubMed ID: 6189729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Solid tumor-derived target cell susceptibility to macrophages and natural killer/natural cytotoxic cells in the rat.
    Zöller M; Matzku S
    Immunobiology; 1983 May; 164(5):349-60. PubMed ID: 6603412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The tumorigenicity of IL-2 gene-transfected murine M-3D melanoma cells is determined by the magnitude and quality of the host defense reaction: NK cells play a major role.
    Schneeberger A; Koszik F; Schmidt W; Kutil R; Stingl G
    J Immunol; 1999 Jun; 162(11):6650-7. PubMed ID: 10352282
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and in vivo characteristics of human squamous cell carcinoma of the head and neck cells engineered to secrete interleukin-2.
    Nagashima S; Reichert TE; Kashii Y; Suminami Y; Chikamatsu K; Whiteside TL
    Cancer Gene Ther; 1997; 4(6):366-76. PubMed ID: 9408607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.